GEHC vs HTFL
GEHC: GE HealthCare is a leading medical technology company providing advanced diagnostic imaging, patient monitoring, and AI-driven clinical software to help clinicians manage complex diseases. HTFL: HeartFlow uses AI-powered software to transform standard cardiac scans into actionable 3D insights for non-invasive coronary artery disease diagnosis and treatment planning.
Side-by-side fundamentals
| Metric | GEHC | HTFL | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $61.41 | $24.23 | |
| Market cap as of 2026-07-23 | $27.9B | $2.2B | |
| P/E as of 2026-07-23 | 14.63 | n/a | |
| PEG as of 2026-07-23 | 2.18 | n/a | |
| Net margin as of 2026-07-23 | +9.1% | -58.4% | GEHC higher |
| Gross margin as of 2026-07-23 | +39.1% | +78.1% | HTFL higher |
| Operating margin as of 2026-07-23 | +12.6% | -43.1% | GEHC higher |
| ROE as of 2026-07-23 | +18.8% | -38.9% | GEHC higher |
| ROA as of 2026-07-23 | +5.3% | -36.4% | GEHC higher |
| Debt / equity as of 2026-07-23 | 0.95 | 0.00 | HTFL lower |
| Revenue growth (YoY) as of 2026-07-23 | +6.0% | +41.3% | HTFL higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | +42.1% | HTFL higher |
| Dividend yield as of 2026-07-23 | +0.2% | n/a | |
| Dividend streak (yrs) SEC XBRL | 3 | n/a | |
| Beta as of 2026-07-23 | 0.84 | 1.99 | |
| 1-year return as of 2026-07-22 close | -16.3% | -12.7% | HTFL higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.